Sort   by:  
 Page size 
MetabolomicsFatty acid transport protein 4 is required for incorporation of saturated ultralong-chain fatty acids into epidermal ceramides and monoacylglycerols
Fatty acid transport protein 4 (FATP4) is an acyl-CoA synthetase that is required for normal permeability barrier in mammalian skin. FATP4 (SLC27A4) mutations cause ichthyosis prematurity syndrome, a nonlethal disorder. In contrast, Fatp4-/- mice die neonatally from a defective barrier. H...
2021-07-15 | MTBLS1138 | MetaboLights
UnknownMagneto-voltaic activity of single-atom iron on reduced graphene oxide for magneto-catalytic conversion of H<sub>2</sub>O<sub>2</sub> into O<sub>2</sub>.
Not available
S-EPMC12628007 | biostudies-literature
UnknownFei-Yan-Qing-Hua decoction attenuates influenza virus infection by enhancing host antiviral response through microbiota-derived acetate.
Not available
S-EPMC11499185 | biostudies-literature
UnknownRed Phosphorus Potassium-Ion Battery Anodes.
Not available
S-EPMC6498114 | biostudies-literature
UnknownDIA-PRM Proteomic Analysis of Phlegm-Dampness Constitution with Glucolipid Metabolic Disorders by the Intervention of Hua Tan Qu Shi Recipe.
Not available
S-EPMC9803578 | biostudies-literature
ProteomicsCajanin Stilbene Acid Inhibited Vancomycin-Resistant Enterococci By Inhibiting Phosphotransferase System
In order to determine the mechanism of Cajanin Stilbene Acid inhibiting vancomycin-resistant enterococci, we compared the changes in protein expression of enterococci V583 strain before and after treated by Cajanin Stilbene Acid.
ORGANISM(S): Enterococcus faecium 
2020-05-27 | PXD017522 | Pride
Cajanin stilbene acid  vancomycin-resistant enterococci  phosphotransferase system 
UnknownIridium Single Atoms to Nanoparticles: Nurturing the Local Synergy with Cobalt-Oxide Supported Palladium Nanoparticles for Oxygen Reduction Reaction.
Not available
S-EPMC11434211 | biostudies-literature
UnknownAn-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir.
Not available
S-EPMC9817059 | biostudies-literature
UnknownDorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
Not available
S-EPMC9871194 | biostudies-literature
UnknownEffects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose Tolerance.
Not available
S-EPMC12585157 | biostudies-literature
Sort   by:  
 Page size